Linking late life depression and Alzheimer's disease: mechanisms and resilience
- PMID: 33134032
- PMCID: PMC7597973
- DOI: 10.1007/s40473-019-00180-7
Linking late life depression and Alzheimer's disease: mechanisms and resilience
Abstract
Purpose of review: This review summarizes recent literature linking Alzheimer's disease (AD) and late life depression (LLD). It describes shared neurobiological features associated with both conditions, as well as factors that may increase resilience to onset and severity of cognitive decline and AD. Finally, we pose a number of future research directions toward improving detection, management, and treatment of both conditions.
Recent findings: Epidemiological studies have consistently shown a significant relationship between LLD and AD, with support for depression as a prodromal feature of AD, a risk factor for AD, and observation of some shared risk factors underlying both disease processes. Three major neurobiological features shared by LLD and AD include neurodegeneration, disruption to cerebrovascular functioning, and increased levels of neuroinflammation. There are also potentially modifiable factors that can increase resilience to AD and LLD, including social support, physical and cognitive engagement, and cognitive reserve.
Summary: We propose that, in the context of depression, neurobiological events, such as neurodegeneration, cerebrovascular disease, and neuroinflammation result in a brain that is more vulnerable to the consequences of the pathophysiological features of AD, lowering the threshold for the onset of the behavioral presentation of AD (i.e., cognitive decline and dementia). We discuss factors that can increase resilience to AD and LLD, including social support, physical and cognitive engagement, and cognitive reserve. We conclude with a discussion of future research directions.
Keywords: Alzheimer’s disease; dementia; depression; late life depression.
Conflict of interest statement
Conflict of Interest Sara Weisenbach reports grants from National Institutes of Health outside the submitted work. Joseph Kim, Dustin Hammers, Kelly Konopacki and Vincent Koppelmans declare no conflicts of interest relevant to this manuscript.
Figures

Similar articles
-
Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer's Disease.Dement Geriatr Cogn Disord. 2021;50(5):414-424. doi: 10.1159/000519453. Epub 2021 Nov 25. Dement Geriatr Cogn Disord. 2021. PMID: 34823241 Review.
-
APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.Int J Geriatr Psychiatry. 2003 Dec;18(12):1075-81. doi: 10.1002/gps.1006. Int J Geriatr Psychiatry. 2003. PMID: 14677138
-
Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.J Alzheimers Dis. 2016 Mar 8;52(1):1-15. doi: 10.3233/JAD-151129. J Alzheimers Dis. 2016. PMID: 27060956 Review.
-
When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression.Front Aging Neurosci. 2018 Feb 23;10:38. doi: 10.3389/fnagi.2018.00038. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29527163 Free PMC article.
-
Crosstalk between Depression and Dementia with Resting-State fMRI Studies and Its Relationship with Cognitive Functioning.Biomedicines. 2021 Jan 16;9(1):82. doi: 10.3390/biomedicines9010082. Biomedicines. 2021. PMID: 33467174 Free PMC article. Review.
Cited by
-
Association between physical activity and mild cognitive impairment in community-dwelling older adults: Depression as a mediator.Front Aging Neurosci. 2022 Sep 8;14:964886. doi: 10.3389/fnagi.2022.964886. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36158532 Free PMC article.
-
Integrating Metabolomics and Network Analysis for Exploring the Mechanism Underlying the Antidepressant Activity of Paeoniflorin in Rats With CUMS-Induced Depression.Front Pharmacol. 2022 Jun 13;13:904190. doi: 10.3389/fphar.2022.904190. eCollection 2022. Front Pharmacol. 2022. PMID: 35770096 Free PMC article.
-
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression.Sci Rep. 2021 Aug 5;11(1):15981. doi: 10.1038/s41598-021-95206-0. Sci Rep. 2021. PMID: 34354136 Free PMC article. Clinical Trial.
-
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.Free Neuropathol. 2022 Jul 8;3:17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan. Free Neuropathol. 2022. PMID: 37284149 Free PMC article.
-
Tailoring Exergames for Clinical Populations: Lessons Learned and Design Considerations for Persons With Dementia and Late-Life Depression.Cureus. 2025 May 5;17(5):e83502. doi: 10.7759/cureus.83502. eCollection 2025 May. Cureus. 2025. PMID: 40470425 Free PMC article.
References
-
-
Kida J, Nemoto K, Ikejima C, Bun S, Kakuma T, Mizukami K, et al. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer’s Disease: A Community-Based Longitudinal Study. J Alzheimers Dis. 2016;51(2):405–15.
• A recent community-based longitudinal study of how depression in MCI increases risk for AD.
-
-
-
Ye Q, Bai F, Zhang Z. Shared Genetic Risk Factors for Late-Life Depression and Alzheimer’s Disease. J Alzheimers Dis. 2016. 08;52(1):1–15.
• Meta-analysis of shared genetic risk for AD and LLD.
-
-
- United Nations, Department of Economics and Social Affairs, Population Division. World population ageing, 2017 highlights. 2017.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials